Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Target Assessment

Target Assessment

Informatics driven Target-identification, assessment and prioritization

Target identification and validation is one of the biggest challenges in the pharmaceutical industry, with many promising treatments failing in the clinic due to efficacy or target-related safety issues. The reason is usually that the underlying hypothesis turns out to be wrong, or there are unwanted consequences of modulating the target. Due diligence around a target early on, can make the difference between success and failure of a program. We offer informatics-driven selection, assessment and prioritization of potential drug targets.

Our offerings

  • Target Dossiers
  • Knowledge graphs for the therapeutic area
  • Target identification and validation

Target dossiers

Target dossier is a compendium of structural, functional, pharmacogenomic, and safety aspects of a target (Figure 1). Automated information retrieval technologies combined with scientific expertise, help in gleaning insights, thereby enabling executive decisions and program design. These modular dossiers serve as a ready -reference for various teams throughout the drug discovery program.

Target dossiers integrate

Comprehensive profiling of a drug target


Our dossiers at a glance

Types of target dossiers


Knowledge graphs

We create knowledge graphs around the therapeutic area of interest which helps to establish relationships, identify key pathways and networks, and understand the mechanism of action (MOA) to elucidate the role of a target in disease. The knowledge graph combines multiomic data with clinical evidence and published information over the protein interaction subnetwork. It generates mechanistic hypotheses, identifies key markers, and helps build disease models. The disease networks can also be extended to the quantitative systems pharmacology (QSP) model.


Target identification and validation

We combine knowledge from multiomics data analysis, network biology and literature mining to identify- the role of the target and assess its therapeutic potential in the disease of interest. Various parameters pertaining to druggability, specificity and efficacy are critically analyzed and scored to create a prioritized set of potential targets. Our holistic approach brings higher rate of clinical success.

Target-Identification-Approach

Syngene process for target identification

For identified set of targets, experimental validation is run in Syngene’s state-of-the-art experimental laboratory in the Biology operating unit.


Animal Health

In addition to the extensive target identification and prioritization work carried out for biopharma companies, we can also help you assess targets for suitability including potential for repurposing drugs/targets in animal health

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details